Minimally invasive, maximally impactful: minimally invasive glaucoma surgery and the changing glaucoma landscape.
Journal
Current opinion in ophthalmology
ISSN: 1531-7021
Titre abrégé: Curr Opin Ophthalmol
Pays: United States
ID NLM: 9011108
Informations de publication
Date de publication:
30 Jul 2024
30 Jul 2024
Historique:
medline:
31
7
2024
pubmed:
31
7
2024
entrez:
31
7
2024
Statut:
aheadofprint
Résumé
The advent of minimally invasive glaucoma surgery (MIGS) procedures has ushered in a new era of interventional glaucoma. MIGS has expanded the treatment options for surgeons necessitating a rethinking of the optimal management strategy for patients with glaucoma. There are several new MIGS devices and procedures available to glaucoma surgeons. With several options available, patient selection is crucial to maximize the utility of MIGS in the context of traditional glaucoma surgery. A management algorithm is presented based on our practice pattern to help guide decision-making for glaucoma surgeons. Although we encourage surgeons to continue to broaden their toolkit, we emphasize the continued importance of teaching the next-generation traditional glaucoma surgery in the MIGS era. Future prospective studies are warranted to elucidate the optimal treatment strategy for patients with glaucoma.
Identifiants
pubmed: 39082111
doi: 10.1097/ICU.0000000000001077
pii: 00055735-990000000-00185
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121:2081–2090.
Boland MV, Ervin AM, Friedman DS, et al. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2013; 158:271–279.
Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120:1268–1279.
Lichter PR, Musch DC, Gillespie BW, et al. CIGTS Study Group Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108:1943–1953.
The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Glaucoma Laser Trial Research Group. Am J Ophthalmol 1995; 120:718–731.
Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. LiGHT Trial Study Group Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet 2019; 393:1505–1516.
The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results. Ophthalmology 1998; 105:1146–1164.
Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. LiGHT Trial Study Group Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension. Ophthalmology 2023; 130:139–151.
Realini T. A history of glaucoma pharmacology. Optom Vis Sci 2011; 88:36–38.
Fellman RL, Mattox C, Singh K, et al. American Glaucoma Society Position Paper: microinvasive glaucoma surgery. Ophthalmol Glaucoma 2020; 3:1–6.
Lavia C, Dallorto L, Maule M, et al. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PLoS One 2017; 12:e0183142.
Razeghinejad MR, Spaeth GL. A history of the surgical management of glaucoma. Optom Vis Sci 2011; 88:E39–E47.
Heuer DK, Lloyd MA, Abrams DA, et al. Which is better? One or two? A randomized clinical trial of single-plate versus double-plate Molteno implantation for glaucomas in aphakia and pseudophakia. Ophthalmology 1992; 99:1512–1519.
Christakis PG, Kalenak JW, Zurakowski D, et al. The Ahmed Versus Baerveldt study: one-year treatment outcomes. Ophthalmology 2011; 118:2180–2189.
Tsai JC. Medication adherence in glaucoma: approaches for optimizing patient compliance. Curr Opin Ophthalmol 2006; 17:190–195.
Newman-Casey PA, Blachley T, Lee PP, et al. Patterns of glaucoma medication adherence over four years of follow-up. Ophthalmology 2015; 122:2010–2021.
Sleath B, Blalock S, Covert D, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology 2011; 118:2398–2402.
Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 2012; 23:96–104.
Holmes DP, Clement CI, Nguyen V, et al. Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery. Clin Exp Ophthalmol 2022; 50:303–311.
Chee WK, Yip VCH, Tecson IO, et al. Comparison of efficacy of combined phacoemulsification and istent inject versus combined phacoemulsification and Hydrus microstent. Clin Ophthalmol 2023; 17:1151–1159.
Hu R, Guo D, Hong N, et al. Comparison of Hydrus and iStent microinvasive glaucoma surgery implants in combination with phacoemulsification for treatment of open-angle glaucoma: systematic review and network meta-analysis. BMJ Open 2022; 12:e051496.
Gunay M, Cigiltepe IB, Turk A, et al. A prospective comparison of 180 versus 360-degree gonioscopy-assisted transluminal trabeculotomy outcomes in pseudoexfoliation glaucoma. J Glaucoma 2024; [Online ahead of print].
Chadha N, Warren JL, Liu J, et al. Seven- and eight-year trends in resident and fellow glaucoma surgical experience. Clin Ophthalmol 2019; 13:303–309.
Arora KS, Robin AL, Corcoran KJ, et al. Use of various glaucoma surgeries and procedures in Medicare beneficiaries from 1994 to 2012. Ophthalmology 2015; 122:1615–1624.